APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,629 | -77.4% | 10,997 | 0.0% | 0.00% | – |
| Q2 2023 | $16,056 | -28.4% | 10,997 | 0.0% | 0.00% | – |
| Q1 2023 | $22,434 | -12.1% | 10,997 | 0.0% | 0.00% | – |
| Q4 2022 | $25,513 | -22.7% | 10,997 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | -15.4% | 10,997 | +1.9% | 0.00% | – |
| Q2 2022 | $39,000 | -58.1% | 10,788 | -32.2% | 0.00% | – |
| Q1 2022 | $93,000 | -24.4% | 15,900 | +1.6% | 0.00% | – |
| Q4 2021 | $123,000 | -49.2% | 15,650 | 0.0% | 0.00% | – |
| Q3 2021 | $242,000 | – | 15,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $39,477,000 | 7.86% |
| RTW INVESTMENTS, LP | 281,402 | $6,312,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 187,995 | $4,217,000 | 0.09% |
| Anson Funds Management LP | 35,587 | $798,000 | 0.08% |
| Alyeska Investment Group, L.P. | 139,172 | $3,122,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 14,022 | $315,000 | 0.03% |
| JBF Capital, Inc. | 3,907 | $88,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,350 | $344,000 | 0.01% |
| Renaissance Technologies | 159,923 | $3,587,000 | 0.00% |
| QS Investors, LLC | 15,650 | $352,000 | 0.00% |